ARCH Venture Partners

ARCH invests primarily in companies co-founded by scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories.

ARCH has raised ten venture funds totaling over $3 billion and has invested in the venture capital rounds for more than 150 companies. ARCH investors include corporations, pension funds, endowment funds, financial institutions, and private investors.

ARCH Venture Partners, established in 1986 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Biotechnology, Life Science, Health Care, Pharmaceutical, Health Diagnostics, Venture Capital, Finance, Business Development, Financial Services, Telecommunications. The organization boasts a portfolio of 484 investments, with an average round size of $89.7M and 107 successful exits. Their recent investments include Quanterix, Flagship Pioneering, Bain Capital Ventures, Xtera, New Enterprise Associates. The highest investment round they participated in was $2950.4B. Among their most notable exits are Quanterix and Flagship Pioneering. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.